Wednesday, July 8, 2026

pharma · Metastatic Pancreatic Adenocarcinoma · Primary Biliary Cholangitis

Ipsen

Ipsen patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

70, Rue Balard, Paris, Île-de-France 75015, FR HQ
6,584 Employees
NMPA registrant Type
Company details
Status
Public
HQ
70, Rue Balard, Paris, Île-de-France 75015, FR
Employees
6,584
Programs
27
Drugs
36
Patents
0
Intelligence · Patents

Ipsen patents

0 pharmaceutical patents indexed for Ipsen. 0 expire within 24 months.

Ipsen has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does Ipsen have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Ipsen patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.